Comparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation

Cancer. 1963 Apr:16:440-3. doi: 10.1002/1097-0142(196304)16:4<440::aid-cncr2820160404>3.0.co;2-g.
No abstract available

MeSH terms

  • Anatomy*
  • Antineoplastic Agents*
  • Breast Neoplasms*
  • Fluoxymesterone*
  • Humans
  • Methyltestosterone*

Substances

  • Antineoplastic Agents
  • calusterone
  • Fluoxymesterone
  • Methyltestosterone